2026 Q1 Portfolio Activity
In 2026 Q1, KVP Capital Advisors, LP maintained a portfolio of 36 distinct positions. The most significant new addition was SUTRO BIOPHARMA INC, now representing 4.22% of the total fund value. They heavily accumulated shares in REVOLUTION MEDICINES INC, increasing the position by 46.2%. Conversely, KVP Capital Advisors, LP completely exited their position in JAZZ PHARMACEUTICALS PLC.
Position History
hover any row below to update
Loading…
KVP Capital Advisors, LP
AUM $134M
Total Positions
36
Quarter
2026 Q1
Top Holding
TERN (17.3%)
Top 10 Concentration
61.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-36 of 36
KVP Capital Advisors, LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERN
TERNS PHARMACEU...
|
Healthcare | 17.32% | 17.20% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
440,000 | $23,196,800 |
$40.40
+31.1%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 10.32% | 12.24% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
42,900 | $13,821,951 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 5.58% | 5.07% |
#3
2
Prev: #5
|
4.2 |
—
|
no change | no change |
P
S
|
2,165,997 | $7,472,690 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 4.57% | 6.40% |
#4
1
Prev: #3
|
3.3 |
—
|
no change | no change |
P
S
|
36,200 | $6,118,524 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 4.22% | — |
#5
Prev: #—
|
5.7 |
—
|
226,575 | — |
NEW
|
226,575 | $5,643,983 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 4.17% | 4.48% |
#6
2
Prev: #8
|
2.7 |
—
|
no change | no change |
P
S
|
53,000 | $5,586,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
ERAS
ERASCA INC
|
Healthcare | 4.11% | — |
#7
Prev: #—
|
5.1 |
—
|
340,000 | — |
NEW
|
340,000 | $5,501,200 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 3.69% | 5.02% |
#8
2
Prev: #6
|
2.5 |
—
|
no change | no change |
P
S
|
414,000 | $4,939,020 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 3.60% | — |
#9
Prev: #—
|
4.9 |
—
|
230,264 | — |
NEW
|
230,264 | $4,817,123 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
INSM
INSMED INC
|
Healthcare | 3.48% | 4.80% |
#10
3
Prev: #7
|
2.4 |
—
|
no change | no change |
P
S
|
28,497 | $4,659,829 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.13% | 3.19% |
#11
2
Prev: #13
|
2.3 |
—
|
no change | no change |
P
S
|
133,000 | $4,189,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.92% | 2.12% |
#12
6
Prev: #18
|
3.7 |
—
|
12,700 | 46.2% |
P
S
|
40,200 | $3,909,450 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.78% | 4.48% |
#13
4
Prev: #9
|
2.1 |
—
|
no change | no change |
P
S
|
58,250 | $3,724,505 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 2.71% | 3.71% |
#14
4
Prev: #10
|
2.1 |
—
|
no change | no change |
P
S
|
121,524 | $3,627,491 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
SVRA
SAVARA INC
|
Healthcare | 2.47% | 3.53% |
#15
4
Prev: #11
|
2.0 |
—
|
no change | no change |
P
S
|
605,280 | $3,304,829 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.10% | 2.24% |
#16
Prev: #16
|
1.8 |
—
|
no change | no change |
P
S
|
4,750 | $2,816,655 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.02% | 3.36% |
#17
5
Prev: #12
|
1.8 |
—
|
no change | no change |
P
S
|
91,000 | $2,703,610 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.98% | — |
#18
Prev: #—
|
4.3 |
—
|
79,700 | — |
NEW
|
79,700 | $2,655,604 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.98% | — |
#19
Prev: #—
|
4.3 |
—
|
500,000 | — |
NEW
|
500,000 | $2,645,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.90% | — |
#20
Prev: #—
|
4.3 |
—
|
300,000 | — |
NEW
|
300,000 | $2,541,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.83% | — |
#21
Prev: #—
|
4.2 |
—
|
125,000 | — |
NEW
|
125,000 | $2,445,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.73% | — |
#22
Prev: #—
|
4.2 |
—
|
31,813 | — |
NEW
|
31,813 | $2,321,395 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.66% | — |
#23
Prev: #—
|
4.2 |
—
|
373,128 | — |
NEW
|
373,128 | $2,220,112 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.65% | 1.92% |
#24
5
Prev: #19
|
1.7 |
—
|
no change | no change |
P
S
|
45,000 | $2,212,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 1.57% | 1.17% |
#25
3
Prev: #22
|
1.6 |
—
|
no change | no change |
P
S
|
230,423 | $2,099,154 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.49% | 2.67% |
#26
11
Prev: #15
|
1.6 |
—
|
no change | no change |
P
S
|
59,700 | $1,998,756 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.45% | 1.10% |
#27
4
Prev: #23
|
1.6 |
—
|
no change | no change |
P
S
|
26,900 | $1,935,455 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 1.02% | 1.07% |
#28
4
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
505,431 | $1,359,609 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 1.02% | 2.22% |
#29
12
Prev: #17
|
1.4 |
—
|
no change | no change |
P
S
|
462,355 | $1,359,324 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.98% | 1.60% |
#30
10
Prev: #20
|
1.4 |
—
|
no change | no change |
P
S
|
32,700 | $1,315,521 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.34% | 0.39% |
#31
5
Prev: #26
|
1.1 |
—
|
no change | no change |
P
S
|
4,000 | $456,560 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
VYNE
VYNE THERAPEUTI...
|
Healthcare | 0.22% | 0.28% |
#32
5
Prev: #27
|
1.1 |
—
|
no change | no change |
P
S
|
500,551 | $299,079 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
N/A
CALL
FULCRUM THERAPE...
|
|
CALL Option | 0.00% | 1.21% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-110,900 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-03-31 | 2026-05-13 | ||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.00% | 2.88% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-17,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-13 | |||
|
N/A
CALL
JAZZ PHARMACEUT...
|
|
CALL Option | 0.00% | 5.10% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-31,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-03-31 | 2026-05-13 |
Showing 1-36 of 36 holdings